( February 27, 2025, 12:19 PM EST) -- AMARILLO, Texas — GenBioPro Inc., the maker of generic mifepristone, one of two drugs used to induce early termination of pregnancy, moved to intervene in a case challenging the U.S. Food and Drug Administration’s approval of the abortion drug, a case that eventually reached the U.S. Supreme Court, which found that the plaintiffs lacked standing and in which the original plaintiffs have now voluntarily dismissed all of their claims but that has been kept alive by a Texas federal judge’s decision to allow intervening states Missouri, Kansas and Idaho to file an amended complaint....